Semi-Solid Dosage Form Market Segmented By Ointments, Pastes, Cream, Plasters, Gels and Rigid Foams Product Type in Skin, Nasal Cavity, Vaginal Cavity, Rectal Cavity, Others Application
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP32922
According to the latest research by Persistence Market Research, the Semi-Solid Dosage Form Market is set to witness growth during 2021-2031. There has been increase in prevalence of skin diseases worldwide owing to the factors from global warming to dermal reactions due to use of medications.
The main problem with topical semi-solid drug dosage form was that its side effects varied from person to person. Research studies which are being carried out to oust this issue will definitely push this market forward.
Also, this dosage form is beginning to rise as an answer to certain ailments whose original treatments were proving to be painful to the care receiver. This is another important factor that will definitely impact the market in a very positive way.
Semi-solid dosage forms contain both solid as well as liquid which makes them viscous in nature. They are used for therapeutic and cosmetics functions in a topical or superficial way. The main drivers for this market is the site-specific action of the administered drug as the mechanism of healing will only take place at the site where it is applied.
The fact the these dosage forms reduce the risk of loss of the drug’s potency due the human body’s first-pass metabolism is a major driver for this market.
Oral drugs can have a drawback of leaving a bitter after test as well as bioavailability at the site of requirement. This issue is resolved by semi-solid drugs as hepatic metabolism along with the topical nature which will prove to be better alternative for bitter drugs. These factor will definitely play a crucial role in driving the market forward.
However, this dosage has some drawbacks that might restrain this market from growing at a desired rate. Semi-solid dosages sometimes tend to cause irritations as well as allergies at the site. Regardless with researches being conducted to improve on the already existing drug delivery systems, researches can find ways to work around these restraints.
According to the MDPI published in 2019, a case study conducted by researchers of Spain, if a semi-solid dosage form can be developed for the parasitic infection of Cutaneous Leishmaniasis (CL). CL is widely treated with intralesional injection which can prove to be painful for some.
So, these researchers aimed to develop an alternative ointment which used gel-based formulation of drug called as Megalumine antimoniate (MA) which is normally used in the intralesional injection for treating CL. The stability, permeation level and other physicochemical properties were then studied.
They at the end concluded that, this ointment proved to be having higher acceptance in the patients. Also having low permeability into the skin results in low drugs level in the blood which ultimately reduces the toxicity of the ointment. These results certainly put up a competitive alternative for the injection used in CL treatment.
U.S. is the most dominant market player in the North American region. Prominent reason for this is adequate amount of government financial support which encouraged researchers’ constantly finding novel ways to use a specific drug form in variety of different ways.
American Academy of Dermatology recently published statistics stating that, skin diseases alone cost U.S. healthcare system US$ 75 billion dollar yearly. Also, 1 in 4 American citizen is impacted by some or the other kind of skin disease. Rise in incidence of skin ailments is also boosting this market in the regional market.
About one third of the world’s population is affected by some or the other kind of skin disease, making it the world’s fourth most common cause of diseases caused in humans.
A 2018 study published by British Association of Dermatologists conducted investigation in adults from 5 European countries said that prevalence of skin diseases was seen higher in the Northern Europe in countries like Germany, Netherlands in comparison with the Southern European countries like Italy, Portugal.
Cost-effective as well as novel formulations and increase in disease prevalence due to heredity, Europe has emerged as second most profitable market after U.S. With increase in prevalence of various type of skin diseases, research in development of drugs that with higher efficiency are rapidly increasing; opening up novel avenues in the market.
Key manufacturers in Semi-Solid Dosage Form Market include:
By Product Type:
By Application:
By Ingredient Type:
By End User:
By Region:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
To know more about delivery timeline for this report Contact Sales
